4
Changes in Ownership
REGENXBIO Inc. Filed Acc 0001562180-19-002018
Chief Financial Officer sold 10,000 shares at an average $60.75 ($607,539)
From the SEC's structured data for this filing
Trades in this filing
Vasista Vittal · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-03-21 | Sale : show line 1 in the form | −8,300 | $60.64 | $503,312 | 230,915 | D |
| 2019-03-21 | Sale : show line 2 in the form | −1,700 | $61.31 | $104,227 | 229,215 | D |
| Open-market sales · 10,000 sh · avg $60.75 · $607,539 | ||||||
Loading xslF345X03/primarydocument.xml…